Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B2cebd45137b41e2a2ee8bd937ebd114f> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B2cebd45137b41e2a2ee8bd937ebd114f NCIT_P378 "NCI" @default.
- B2cebd45137b41e2a2ee8bd937ebd114f type Axiom @default.
- B2cebd45137b41e2a2ee8bd937ebd114f annotatedProperty IAO_0000115 @default.
- B2cebd45137b41e2a2ee8bd937ebd114f annotatedSource NCIT_C180413 @default.
- B2cebd45137b41e2a2ee8bd937ebd114f annotatedTarget "An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the tumor-associated antigen (TAA) Claudin18.2 (CLDN18.2; A2 isoform of claudin-18) conjugated via a cleavable linker, to the microtubule-disrupting cytotoxic agent monomethyl auristatin E (MMAE), with potential antineoplastic activity. Upon administration, anti-CLDN18.2 ADC CMG901 specifically targets and binds to CLDN18.2 expressed on tumor cells. Upon internalization and the release of MMAE, MMAE targets and binds to tubulin, and inhibits microtubule polymerization. This results in G2/M phase cell cycle arrest and apoptosis in CLDN18.2-expressing tumor cells. CLDN18.2, a tight junction protein and stomach-specific isoform of claudin-18, is expressed on a variety of tumor cells. Its expression in healthy tissues is strictly confined to short-lived differentiated epithelial cells of the gastric mucosa." @default.